Harrison Hockenberry

Harrison joined the Goodwin lab in May of 2022 as a research technician and clinical research assistant. He graduated from the University of North Carolina in Chapel Hill in 2022 where he earned bachelor’s degrees in philosophy and neuroscience. Harrison’s clinical research interests focus on health-related quality-of-life outcomes in the spine oncology population. Specifically, how we can leverage spinopelvic parameters to predict mechanical complications and inform surgical decision-making. Harrison currently works on a number of adjunct projects including investigations into palliative care perceptions, how biomarkers influence surgical decision-making, and the relationship between urbanicity and clinical outcomes in spine oncology. Harrisons basic science interests involve the enzyme UGDH and how it contributes to metastasis and drug resistance in the context of hormonally regulated cancers.